J&J makes takeover approach for Swiss drugmaker Actelion: Bloomberg

(Reuters) - U.S. healthcare company Johnson & Johnson has approached Swiss biotechnology firm Actelion Ltd about a potential takeover, Bloomberg reported on Thursday, citing people it said were familiar with the matter.

J&J makes takeover approach for Swiss drugmaker Actelion: Bloomberg
Read More


Bagikan Berita Ini